Please join us for an afternoon of learning about the importance of and the science behind mutational testing with pathologist and GIST specialist, Dr. Christopher Corless of Portland’s Oregon Health and Science University.

This presentation will review the role of mutational analysis to subclassify GI Stromal Tumors.  This can be valuable in defining prognosis and predicting responses to systemic treatments.

The webcast will include time for a Question & Answer session on topics related to the presentation. 

Please note: We cannot provide individual medical advice during this Webinar. Information provided in this Webinar is not intended as a substitute for your physician’s guidance and care.


Date: Thursday, August 27, 2015

Time: 12:00 PM EDT

Duration: 1 hour

Host: Sara Rothschild

Presenter Information

chris corless

 Christopher Corless

 A member of the LRG Research Team, Dr. Corless has expertise in the application of  molecular diagnostics to the classification and progonistication of solid tumors. His clinical  interests include liver transplant pathology, gastrointestinal pathology and genitourinary  pathology.  He currently serves as a Professor of Pathology and Chief Medical Officer of  OHSU’s Knight Diagnostic Laboratories.